StockNews.com started coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research note published on Friday morning. The firm issued a sell rating on the stock. Several other research analysts also recently commented on ONCT. HC Wainwright raised shares of Oncternal Therapeutics from a neutral rating to a buy rating and set […]
Oncternal Therapeutics, Inc. (NASDAQ:ONCT – Get Free Report) has been given an average rating of “Hold” by the six ratings firms that are presently covering the company, Marketbeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average twelve-month price […]
StockNews.com assumed coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research note published on Wednesday morning. The firm issued a sell rating on the stock. ONCT has been the topic of a number of other reports. Cantor Fitzgerald reissued a neutral rating and issued a $1.30 target price on shares of […]
StockNews.com initiated coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a report issued on Monday. The brokerage issued a sell rating on the stock. Several other research firms also recently weighed in on ONCT. HC Wainwright upgraded shares of Oncternal Therapeutics from a neutral rating to a buy rating and set a […]
StockNews.com began coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research note published on Monday morning. The brokerage issued a sell rating on the stock. Several other analysts have also recently commented on ONCT. HC Wainwright upgraded shares of Oncternal Therapeutics from a neutral rating to a buy rating and set […]